SG10201704812TA - Methods and compositions related to annexin 1-binding compounds - Google Patents
Methods and compositions related to annexin 1-binding compoundsInfo
- Publication number
- SG10201704812TA SG10201704812TA SG10201704812TA SG10201704812TA SG10201704812TA SG 10201704812T A SG10201704812T A SG 10201704812TA SG 10201704812T A SG10201704812T A SG 10201704812TA SG 10201704812T A SG10201704812T A SG 10201704812TA SG 10201704812T A SG10201704812T A SG 10201704812TA
- Authority
- SG
- Singapore
- Prior art keywords
- annexin
- methods
- binding compounds
- compositions related
- compositions
- Prior art date
Links
- 108090000663 Annexin A1 Proteins 0.000 title 1
- 102100040006 Annexin A1 Human genes 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28983309P | 2009-12-23 | 2009-12-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201704812TA true SG10201704812TA (en) | 2017-07-28 |
Family
ID=43923683
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201704812TA SG10201704812TA (en) | 2009-12-23 | 2010-12-23 | Methods and compositions related to annexin 1-binding compounds |
| SG2012046652A SG181899A1 (en) | 2009-12-23 | 2010-12-23 | Methods and compositions related to annexin 1-binding compounds |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2012046652A SG181899A1 (en) | 2009-12-23 | 2010-12-23 | Methods and compositions related to annexin 1-binding compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US9610359B2 (enrdf_load_stackoverflow) |
| EP (1) | EP2515944B1 (enrdf_load_stackoverflow) |
| JP (2) | JP6184101B2 (enrdf_load_stackoverflow) |
| CA (1) | CA2784645C (enrdf_load_stackoverflow) |
| SG (2) | SG10201704812TA (enrdf_load_stackoverflow) |
| WO (1) | WO2011079304A1 (enrdf_load_stackoverflow) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10030036B2 (en) * | 2009-05-15 | 2018-07-24 | Lahjavida, Llc | Method and dyes for detecting and destroying cancer cells |
| CN102898527B (zh) | 2011-07-25 | 2016-12-21 | 三星电子株式会社 | 融合蛋白、药物组合物及预防或治疗癌症的方法 |
| PL3468621T3 (pl) * | 2016-06-10 | 2023-01-30 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Domena rdzeniowa aneksyn i jej zastosowania w dostarczaniu antygenu i szczepieniu |
| ES2901232T3 (es) * | 2016-08-16 | 2022-03-21 | Aist | Péptido diana de tumor maligno |
| US20200030452A1 (en) * | 2016-09-30 | 2020-01-30 | IF7Cure, Inc. | Process for the Manufacture of a Tumor-Vasculature Targeting Antitumor Agent |
| JP6856227B2 (ja) * | 2017-02-09 | 2021-04-07 | 株式会社Ｃｉｃｓ | 計測装置 |
| JP6613499B2 (ja) * | 2017-08-24 | 2019-12-04 | 学校法人藤田学園 | 細胞殺傷剤 |
| KR102510514B1 (ko) * | 2018-01-09 | 2023-03-14 | 각코호진 후지타 가쿠엔 | 세포 살상제 |
| WO2019222618A1 (en) * | 2018-05-17 | 2019-11-21 | The Trustees Of Columbia University In The City Of New York | Methods for treating, preventing and detecting the prognosis of colorectal cancer |
| US20210138274A1 (en) * | 2018-06-20 | 2021-05-13 | Hirosaki University | Accumulative boron 10 medicine for boron neutron capture therapy for selectively or locally targeting tumor tissues in short time |
| JP7224628B2 (ja) * | 2019-02-01 | 2023-02-20 | 国立研究開発法人産業技術総合研究所 | 抗ｍｃ１６抗体 |
| US12109276B2 (en) | 2019-03-15 | 2024-10-08 | Lahjavida, Llc | Near-infrared dyes and conjugates for targeting tumors |
| WO2020197943A1 (en) * | 2019-03-26 | 2020-10-01 | Shimadzu Corporation | Photoimmunotherapy and pharmaceutical agent used therefor |
| CN111120645B (zh) * | 2019-12-30 | 2021-10-08 | 潍柴动力股份有限公司 | 一种挡位控制方法、装置及电子设备 |
| US12370266B2 (en) | 2022-09-13 | 2025-07-29 | Core Quantum, Inc. | Polymer composite nanomaterial encapsulation system |
| CN116199748B (zh) * | 2023-01-16 | 2025-08-05 | 中国地质大学（武汉） | 多肽荧光探针及其在检测活细胞内聚集蛋白中的应用 |
| CN116606351B (zh) * | 2023-04-17 | 2025-04-18 | 合肥师范学院 | 一种基于理性分子设计构建的抗菌肽hsp-m4及制备方法和应用 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1016978B (de) | 1955-05-16 | 1957-10-03 | Iashellia Res Ltd | Mittel zur Bekaempfung des Pflanzenwachstums |
| CH588887A5 (enrdf_load_stackoverflow) | 1974-07-19 | 1977-06-15 | Battelle Memorial Institute | |
| JPS5186117A (en) | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4418052A (en) | 1980-08-12 | 1983-11-29 | Wong Dennis W | Diagnostic compositions and method for radiologic imaging of fibrinogen deposition in the body |
| US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
| US4761288A (en) | 1984-09-24 | 1988-08-02 | Mezei Associates Limited | Multiphase liposomal drug delivery system |
| US5628936A (en) | 1987-03-13 | 1997-05-13 | Micro-Pak, Inc. | Hybrid paucilamellar lipid vesicles |
| US5474848A (en) | 1987-03-13 | 1995-12-12 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US4853228A (en) | 1987-07-28 | 1989-08-01 | Micro-Pak, Inc. | Method of manufacturing unilamellar lipid vesicles |
| US5011686A (en) | 1987-09-21 | 1991-04-30 | Creative Biomolecules, Inc. | Thrombus specific conjugates |
| US5013497A (en) | 1988-03-03 | 1991-05-07 | Micro-Pak, Inc. | Method and apparatus for producing lipid vesicles |
| US5024829A (en) | 1988-11-21 | 1991-06-18 | Centocor, Inc. | Method of imaging coronary thrombi |
| US5643873A (en) | 1992-05-06 | 1997-07-01 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1 |
| DE69407292T2 (de) | 1993-06-30 | 1998-06-25 | Genentech Inc | Verfahren zur herstellung von liposomen |
| US6719972B1 (en) * | 1994-06-03 | 2004-04-13 | Repligen Corporation | Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies |
| US5897945A (en) | 1996-02-26 | 1999-04-27 | President And Fellows Of Harvard College | Metal oxide nanorods |
| US6506564B1 (en) | 1996-07-29 | 2003-01-14 | Nanosphere, Inc. | Nanoparticles having oligonucleotides attached thereto and uses therefor |
| GB9708265D0 (en) | 1997-04-24 | 1997-06-18 | Nycomed Imaging As | Contrast agents |
| JP4554077B2 (ja) | 1998-06-11 | 2010-09-29 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | ピラジノンプロテアーゼインヒビター |
| US6451969B1 (en) * | 1999-01-15 | 2002-09-17 | The Burnham Institute | Methods for inhibiting tumor metastasis, and peptides useful therfor |
| US6716452B1 (en) * | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| US6530944B2 (en) | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
| US20040037775A1 (en) * | 2000-08-01 | 2004-02-26 | Siahaan Teruna J. | Leukocyte internalized peptide-drug conjugates |
| DE60124759T2 (de) | 2000-11-30 | 2007-03-15 | The Penn State Research Foundation | Dna methyl transferase inhibitoren |
| DK1548027T3 (da) * | 2002-09-27 | 2008-05-13 | Nihon Mediphysics Co Ltd | Forbindelse, som bindes til leukocytter, og lægemiddel indeholdende forbindelsen i mærket tilstand som den aktive bestanddel |
-
2010
- 2010-12-23 SG SG10201704812TA patent/SG10201704812TA/en unknown
- 2010-12-23 EP EP10803326.7A patent/EP2515944B1/en active Active
- 2010-12-23 JP JP2012546245A patent/JP6184101B2/ja active Active
- 2010-12-23 CA CA2784645A patent/CA2784645C/en active Active
- 2010-12-23 SG SG2012046652A patent/SG181899A1/en unknown
- 2010-12-23 WO PCT/US2010/062072 patent/WO2011079304A1/en active Application Filing
- 2010-12-23 US US13/515,930 patent/US9610359B2/en active Active
-
2015
- 2015-03-16 JP JP2015051656A patent/JP6331030B2/ja active Active
-
2017
- 2017-04-04 US US15/478,699 patent/US20170326245A1/en not_active Abandoned
-
2021
- 2021-04-26 US US17/240,714 patent/US20210260202A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20210260202A1 (en) | 2021-08-26 |
| CA2784645C (en) | 2020-04-28 |
| US20170326245A1 (en) | 2017-11-16 |
| US9610359B2 (en) | 2017-04-04 |
| SG181899A1 (en) | 2012-07-30 |
| CA2784645A1 (en) | 2011-06-30 |
| US20120251453A1 (en) | 2012-10-04 |
| JP6331030B2 (ja) | 2018-05-30 |
| JP2013515745A (ja) | 2013-05-09 |
| JP2015110668A (ja) | 2015-06-18 |
| EP2515944B1 (en) | 2020-04-22 |
| EP2515944A1 (en) | 2012-10-31 |
| JP6184101B2 (ja) | 2017-08-23 |
| WO2011079304A1 (en) | 2011-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201704812TA (en) | Methods and compositions related to annexin 1-binding compounds | |
| IL263729A (en) | Preparations and methods for removing biofilms | |
| HRP20181658T1 (hr) | Kruti pripravci | |
| AP3106A (en) | Antiparisitic dihydroazole compounds and compositions comprising same | |
| SI3812360T1 (sl) | Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo | |
| IL222291A0 (en) | Compositions and methods of synthesis of pyridinoylpiperidine | |
| ZA201207093B (en) | Solid compositions | |
| ZA201200311B (en) | Skincare compositions | |
| GB2486127B (en) | Improved deicer composition | |
| EP2457581A4 (en) | COMPOSITION FOR EXTERNAL PREPARATION FOR THE SKIN | |
| PL2579859T3 (pl) | Kompozycja stała zawierająca iwabradynę | |
| ZA201201645B (en) | Cosmetic composition | |
| ZA201303661B (en) | Cleansing composition | |
| GB0920879D0 (en) | Cosmetic composition | |
| EP2612652A4 (en) | DETERGENT COMPOSITION | |
| EP2484370A4 (en) | COMPOSITION WITH LIPOLYSIS-PROMOTING EFFECT | |
| GB0901494D0 (en) | Compositions and Methods | |
| PT2785769E (pt) | Composição endurecedora de epóxi e composições derivadas | |
| GB201009275D0 (en) | Improvements in or relating to compositions | |
| GB0900582D0 (en) | Tropical composition | |
| EP2381950A4 (en) | COMPOSITIONS AND METHOD FOR THEIR USE | |
| EP2488624A4 (en) | STABILIZED SURFACTANT-OXIDANT COMPOSITIONS AND METHODS THEREOF | |
| GB201005219D0 (en) | Anti-icing compositions | |
| HK1175705A (en) | Methods and compositions related to clot-binding compounds | |
| GB201013662D0 (en) | Herbal composition |